Global Cord Blood Corp Asset Turnover Ratio (CO), as of fourth quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Global Cord Blood Corp  (NYSE: CO)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Global Cord Blood Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Global Cord Blood Corp asset turnover ratio, the ability of Global Cord Blood Corp's assets to generate revenue in the fourth quarter 2022, increased sequentially to 0.16 in the fourth quarter (Mar 31 2022), yet the ratio remained below the average, as CO's position remain challenging.

Within sector 12 more businesses have achieved higher asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2022 compared to previous quarter at no. 1306.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CO Asset Turnover Ratio (Mar 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2021)
IV. Quarter
Y / Y Asset Change 6.59 % 18.35 % 16.64 % 18.35 % 19.99 %
Y / Y Revenue Change 10.8 % - - - 2.6 %
Asset Turnover Ratio (TTM) 0.16 - - - 0.21
CO's Total Ranking # 1306 # 1306 # 0 # 1307 # 0
Seq. Asset Change 9.01 % -5.26 % 5.55 % -2.23 % 21.04 %
Seq. Revenue Change - - - - 265.08 %



Asset Turnover Ratio Company Ranking
Within: No.
Healthcare Facilities Industry # 13
Healthcare Sector # 133
Overall Market # 1306

Asset Turnover Ratio Statistics
High Average Low
11.72 8.77 5.28
(Mar 31 2020)   (Mar 31 2016)




CO Company Profile • Back to CO Efficiency Comparisons • Compare CO Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2022 Assets at quarter ending Mar 31 2022
Cumberland Pharmaceuticals Inc   0.41 $ 36.623  Millions$ 89.395  Millions
Neuronetics Inc   0.41 $ 57.205  Millions$ 140.583  Millions
Brookdale Senior Living Inc   0.41 $ 2,639.677  Millions$ 6,490.682  Millions
Teleflex Incorporated  0.40 $ 2,817.353  Millions$ 6,962.845  Millions
Ispecimen inc   0.40 $ 10.690  Millions$ 26.559  Millions
Science 37 Holdings Inc   0.40 $ 65.845  Millions$ 163.792  Millions
Aytu Biopharma Inc  0.40 $ 92.703  Millions$ 231.973  Millions
Q Biomed inc   0.40 $ 0.271  Millions$ 0.684  Millions
Ironwood Pharmaceuticals inc   0.39 $ 422.437  Millions$ 1,074.224  Millions
Invo Fertility Inc   0.39 $ 3.638  Millions$ 9.266  Millions
Perrigo Company Plc  0.39 $ 4,202.500  Millions$ 10,740.350  Millions
Akebia Therapeutics Inc   0.39 $ 222.973  Millions$ 570.370  Millions
Biodesix Inc   0.39 $ 32.188  Millions$ 82.387  Millions
Surgery Partners Inc   0.39 $ 2,308.900  Millions$ 5,914.825  Millions
Abbvie Inc   0.39 $ 56,725.000  Millions$ 146,642.500  Millions
Boston Scientific Corporation  0.38 $ 12,162.000  Millions$ 31,902.750  Millions
Neurometrix Inc   0.38 $ 8.400  Millions$ 22.050  Millions
Exagen Inc   0.38 $ 48.106  Millions$ 126.646  Millions
Ati Physical Therapy Inc   0.38 $ 632.631  Millions$ 1,668.713  Millions
Assertio Holdings inc   0.38 $ 120.713  Millions$ 319.251  Millions
Scientific Industries Inc   0.38 $ 11.017  Millions$ 29.188  Millions
Urogen Pharma Ltd   0.38 $ 54.121  Millions$ 143.458  Millions
Signify Health Inc   0.38 $ 809.900  Millions$ 2,154.275  Millions
Abcellera Biologics Inc   0.37 $ 489.043  Millions$ 1,308.862  Millions
Supernus Pharmaceuticals inc   0.37 $ 601.349  Millions$ 1,614.192  Millions
Envista Holdings Corporation  0.37 $ 2,431.100  Millions$ 6,547.450  Millions
Arrowhead Pharmaceuticals Inc   0.37 $ 263.417  Millions$ 714.700  Millions
Ani Pharmaceuticals Inc  0.37 $ 226.092  Millions$ 616.764  Millions
Amicus Therapeutics inc   0.37 $ 317.827  Millions$ 868.911  Millions
Myovant Sciences Ltd   0.36 $ 230.972  Millions$ 632.903  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.